ArticleMolecules (Basel, Switzerland)2022

Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors.

Mabrouk Horchani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.